Login

Company Executives

Officer Age In this role 2025 pay Source
David Hung Also a director
President, Chief Executive Officer and Director
68 Not stated Not reported
Philippe Sauvage
Chief Financial Officer, Principal Financial Officer
49 Since 2024
2 years
$1,478,677
David Liu
Chief Medical Officer
56 Since 2022
4 years
Not reported
Colleen Sjogren
Chief Commercial Officer
56 Since 2024
2 years
Not reported
Gary Hattersley
CHIEF SCIENTIFIC OFFICER
Title from the Form 4 dated Aug 19, 2026
Not stated Not stated Not reported
Kerry Wentworth
CHIEF REGULATORY OFFICER
Title from the Form 4 dated Jun 23, 2026
Not stated Not stated Not reported
Stacy Markel
CHIEF PEOPLE OFFICER
Title from the Form 4 dated Jun 23, 2026
Not stated Not stated Not reported
Dongfang Liu
CHIEF MEDICAL OFFICER
Title from the Form 4 dated Apr 17, 2026
Not stated Not stated Not reported
Moses Makunje
VP Finance, Principal Accounting Officer
48 Not stated Not reported

Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.

Directors
7
serving now
Independent
6 of 6
stated in the proxy; 1 not stated
Average tenure
5.4 years
from year joined
CEO also chairs the board
Yes
David Hung, M.D.
Director Age On board Independent Committees Other public boards 2025 pay Source
David Hung, M.D.
68 2018
8 years
Not stated None stated NovoCure Ltd. Paid as CEO
Robert B. Bazemore, Jr.
58 2020
6 years
Independent None stated Ardelyx, Inc., Akari Therapeutics, Plc $483,000
Kim Blickenstaff
73 2019
7 years
Independent
audit
None stated $436,250
Robert Mashal, M.D.
67 2024
2 years
Independent
nominating and corporate governance
None stated $422,500
Min Cui, Ph.D.
57 2024
2 years
Independent
compensation
None stated Not stated
W. Anthony Vernon
70 2019
7 years
Independent
compensation · Chair
NovoCure Ltd. $446,000
Kathryn E. Falberg
66 2020
6 years
Independent
audit · Chair
Arcus Biosciences, Inc., The Trade Desk, Inc. $445,000

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

No related-party transactions disclosed

The proxy filed Apr 10, 2026 describes a review policy but reports no transactions.

Read the policy in the proxy

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support